BofA analyst Joanna Gajuk raised the firm’s price target on BrightSpring Health (BTSG) to $66 from $63 and keeps a Buy rating on the shares. The tone of CFO Jennifer Phipps at the BofA Healthcare Conference was “bullish coming out of another beat and raise,” reports the analyst. who applies a higher multiple on increased confidence in execution.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- BrightSpring Health price target raised to $62 from $48 at Morgan Stanley
- BrightSpring Health price target raised to $61 from $52 at Mizuho
- BrightSpring Health price target raised to $60 from $50 at Deutsche Bank
- BrightSpring Health price target raised to $60 from $52 at BMO Capital
- BrightSpring Health price target raised to $65 from $60 at TD Cowen